As per a report published in the Financial Times, Siemens Healthineers (SMMNY.PK) is planning to buy Advanced Accelerator Applications, a Novartis company, which is focused exclusively on radioligand therapy and precision imaging. The deal could be valued above 200 million euros.
Advanced Accelerator Applications is specialized in the development of radioligand therapies, a novel approach to cancer care. The company's mission is to transform patients' lives by developing and delivering targeted radioligand therapies and precision diagnostic solutions for oncology.
Advanced Accelerator Applications was founded in 2002 by physicist Stefano Buono, and was acquired by Novartis in 2018.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.